Effectiveness of and factors associated with clinical response to methotrexate under daily life conditions in Asian patients with psoriasis: A retrospective cohort study

Pharmacogenetic markers to predict the clinical response to methotrexate in south Indian Tamil patients with psoriasis

(2017) S. Indhumathi et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Metabolic syndrome and psoriasis severity in South-East Asian patients: An investigation of potential association using current and chronological assessments

(2016) Leena Chularojanamontri et al.   JOURNAL OF DERMATOLOGY

Safety and Efficacy of Methotrexate in Psoriasis: A Meta-Analysis of Published Trials

(2016) Jonathan West et al.   PLoS One

Factors Associated with Drug Survival of Methotrexate and Acitretin in Patients with Psoriasis

(2015) G Shalom et al.   ACTA DERMATO-VENEREOLOGICA

CCL20andIL22Messenger RNA Expression After Adalimumab vs Methotrexate Treatment of Psoriasis

(2015) Ari M. Goldminz et al.   JAMA Dermatology

Efficacy and Safety of Systemic Treatments for Psoriasis in Elderly Patients

(2014) S Piaserico et al.   ACTA DERMATO-VENEREOLOGICA

The efficacy of methotrexate plus pioglitazone vs. methotrexate alone in the management of patients with plaque-type psoriasis: a single-blinded randomized controlled trial

(2014) Vahide Lajevardi et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study

(2013) M. Esposito et al.   BRITISH JOURNAL OF DERMATOLOGY

Efficacy and safety of systemic methotrexate in two fixed doses of 10 mg or 25 mg orally once weekly in adult patients with severe plaque-type psoriasis: a prospective, randomized, double-blind, dose-ranging study

(2012) S. Dogra et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Methotrexate vs. fumaric acid esters in moderate-to-severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditions

(2012) M. Inzinger et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1)

(2011) J. Barker et al.   BRITISH JOURNAL OF DERMATOLOGY

Relationship between methotrexate dosing and clinical response in patients with moderate to severe psoriasis: subanalysis of the CHAMPION study

(2011) J.-H. Saurat et al.   BRITISH JOURNAL OF DERMATOLOGY

A 52-Week Trial Comparing Briakinumab with Methotrexate in Patients with Psoriasis

(2011) Kristian Reich et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fumarates vs. methotrexate in moderate to severe chronic plaque psoriasis: a multicentre prospective randomized controlled clinical trial

(2010) S. Fallah Arani et al.   BRITISH JOURNAL OF DERMATOLOGY

Efficacy and safety of mycophenolate mofetil vs. methotrexate for the treatment of chronic plaque psoriasis

(2010) M Akhyani et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Methotrexate versus traditional Chinese medicine in psoriasis: a randomized, placebo-controlled trial to determine efficacy, safety and quality of life

(2009) S. G. Y. Ho et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Anti–tumour necrosis factor-α therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study

(2008) P Gisondi et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY